États-Unis · Plateformes & données · Yahoo Finance

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Publié par Yahoo Finance · États-Unis il y a 9 h

Solventum (NYSE: SOLV), a leader in advanced wound healing, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

À lire aussi

Haemonetics wins approval of PerQseal Elite vascular closure system

Worried About the Stock Market? This High-Yielding ETF Can Provide Stability and Generate Passive Income for Decades

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

US set to announce certification of Boeing 737 MAX 10 on Tuesday, sources say

Anthropic is AI trade's last big hope for a major IPO this year

Gartner Warns $3.5 Trillion AI Investments In Jeopardy, Reiterates Returns Don’t Justify Neocloud Buildout

Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*

Partager

À lire aussi

Haemonetics wins approval of PerQseal Elite vascular closure system

Worried About the Stock Market? This High-Yielding ETF Can Provide Stability and Generate Passive Income for Decades

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

US set to announce certification of Boeing 737 MAX 10 on Tuesday, sources say

Anthropic is AI trade's last big hope for a major IPO this year

Gartner Warns $3.5 Trillion AI Investments In Jeopardy, Reiterates Returns Don’t Justify Neocloud Buildout